GMP Cell Banking Service Market
GMP Cell Banking Service Market Study by Mammalian, Microbial, Insect, Yeast, Avian, Stem, and Other Cell Types for Biopharmaceutical Companies and CROs from 2024 to 2034
Analysis of GMP Cell Banking Service Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
GMP Cell Banking Service Market Outlook (2024 to 2034)
The global GMP cell banking service market is expected to garner a revenue of around US$ 882.1 million in 2024. Market assessment on a global scale reveals the demand for GMP cell banking services to rise at a healthy 13.5% CAGR from 2024 to 2034. The assessment report further predicted a valuation of US$ 3,123.5 million by 2034 end.
Key Market Growth Drivers
- Fast-developing and expanding biopharmaceutical sectors after the pandemic have spawned a lucrative growth of GMP cell banking services worldwide.
- The rising complexity of cell-based therapies has surged the requirement for expert cell banking for accelerated drug discovery.
- Reputable GMP cell banking services that can accommodate global distribution and regulatory requirements are gaining more traction these days.
- The commercialization of biopharmaceutical manufacturing facilities in recent years has also altered the GMP cell banking service market dynamics.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024) | US$ 882.1 million |
| Forecast Market Value (2034) | US$ 3,123.5 million |
| Global Market Growth Rate (2024 to 2034) | 13.5% CAGR |
| Microbial Segment Growth Rate (2024 to 2034) | 14.3% |
| Contract Manufacturing Organizations Segment Growth Rate (2024 to 2034) | 13.9% |
| North America Market Share (2024) | 47.9% |
| Western Europe Market Share (2024) | 28.6% |
| Key Companies Profiled | WuXi AppTec; Charles River Laboratories; Eurofins Scientific; Merck KGaA; Lonza; SGS Life Sciences Ltd.; ViruSure; Austrianova; Goodwin Biotechnology; Paragon Bioservices; Bio Reliance; Sartorius; Thermo Fisher; BSL Bioservice; Cleancells; Covance |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Factors Drive the Global Surge in GMP Cell Banking Service Demand?
“Pharmaceutical Industries are at the Helm of Cell Line Banking Services Market Growth”
Pharmaceutical firms outsource GMP-compliant cell banking services to store and deliver master and working cell banks safely. At the moment, the market for biologics, cell therapies, and gene therapies is expanding fast, and there has been a steep rise in cell banking systems worldwide.
The increasing variety of cell-based therapeutics, such as personalized medicine and regenerative therapies, has increased the demand for cell banks in the pharmaceutical industry. GMP cell banking and storage services that are tailored to the specific requirements of the biopharmaceutical industry are the cornerstones of the research and development of new treatments.
“Diversification and Specialization of Biological Sample Storage is the Key to Growth”
There is a growing need for GMP cell banking services because of the rising demand for clinical trials and the emerging trend for cell-based medicines in the recent past. As GMP-compliant cell banks have become necessary for biopharmaceutical businesses undertaking clinical trials, the overall market is expected to strengthen fast in the coming days.
In recent years, specialized GMP cell banking requirements have also surged due to ongoing improvements in cell line creation for medicinal purposes. Similarly, GMP-compliant banking services are essential for maintaining the integrity and unique qualities of new cell lines that researchers and developers are investigating for vaccination development.
Which Factors Present Challenges to the Expansion of the GMP Cell Banking Service Market?
“Energy Consumption, Contamination, and Outmoded Cell Lines Limit the Market Expansion”
Cell line contamination at GMP cell banks is a significant concern, given that diverse types of cell lines and their variants are stored at such organizations. Maintaining the stability of cell lines over time also entails higher energy consumption, which can add up to the cost of end products developed utilizing commonly available cell lines.
The emergence of rare and novel variants of pathogens has resulted in biopharmaceutical companies often requiring unique cell lines based on the specific characteristics of drugs to be developed. In such situations, the end users go for in-house development of new cell lines rather than depending on cell banks, that are mostly a repository of outmoded cell lines.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
| Country | Regional Market CAGR (2024 to 2034) |
|---|---|
| United States | 13.1% |
| Canada | 12.7% |
| Germany | 12% |
| United Kingdom | 10.7% |
Which Factors Position the United States as a Thriving Market for GMP Cell Banking Service?
“Strict Regulations by USFDA have Accelerated the GMP Cell Banking Services Advancement”
The market in North America is estimated to be valued at US$ 423 million in 2024. The United States dominates the market in North America with an estimated CAGR of 13.1% through the forecast years.
Good manufacturing practices or GMP rules are mandatory in the United States due to the strict regulatory environment in the biopharmaceutical and cell therapy sectors. So, the regional market is up there to adopt cGMP cell banking and storage services to guarantee adherence to FDA legal criteria.
Why has the Demand for GMP Cell Banking Services in Canada Skyrocketed in the Recent Year?
“Canada Players Improving Their Cellular Storage Solutions to Compete with Global Players”
Canada holds around 22.8% of the good manufacturing practice cell banking services market in North America. Over the projection years, it is expected to grow at an annual growth rate of 12.7% from 2024 to 2034.
GMP cell banking services are strengthening in Canada with the growing acceptability and use of cell therapy treatments in the country. Players in Canada are also entering the global competition by offering records and procedures that satisfy global health authorities' standards.
Why Germany Remains the Lucrative Market for Quality Controlled Cell Banking Services?
“Emerging Biopharmaceutical Research Institutes are Rising Demand in Germany”
Germany contributes to almost one-third of cell storage and retrieval requirements in Europe. With an estimated market valuation of US$ 78 million in 2024, the GMP cell line maintenance market in Germany is forecast to progress at a 12% CAGR through 2034.
Regional players who can handle the logistical issues associated with cross-border cell banking are expected to remain crucial partners for many international corporations located in Germany. Opportunities for German cell banking service providers are also expected to emerge more from the growing trend of outsourcing several stages of biopharmaceutical research to adjacent European countries.
Why is the United Kingdom Dominating the Global GMP Cell Banking Service Market in Europe?
“The United Kingdom Iodine Industry Sets the Standard with Cutting-Edge Extraction”
GMP cell-line banking services in the United Kingdom are estimated to create a revenue of US$ 63 million in 2024. This regional market is further predicted to witness a growth rate of 10.7% between 2024 and 2034.
The need for GMP cell banking services has been fueled in the United Kingdom with the rapidly growing market for gene and cell treatments after the pandemic outbreak in 2020. This regional market has witnessed tremendous growth in the last two years, driven by ground-breaking discoveries and approvals for the discovery of innovative medicines.
Category-wise Insights
Why Mammalian Cells Rule the Global Biopreservation Services Market?
“Resemblance to Human Protein Makes Mammalian Cells an Ideal Category for Banking Service Providers”
The revenue accumulated by service providers only from the storage of mammalian cells is estimated to be around US$ 592.5 million in 2024. Over the projected period, this segment is projected to grow at a 13.4% rate per year.
Mammalian cells, in particular Chinese hamster ovary (CHO) cells, can produce proteins that bear a striking resemblance to human proteins. The pharmaceutical industry's rising need for complicated biologics such as monoclonal antibodies, vaccines, and cell treatments is expected to propel the mammalian cell banking segment to new heights.
Which Cell Type Segment is Expected to Create More Opportunities for Market Players?
“Diverse Applications of Microbial Cells Makes its Preservation more Economical”
According to market projections, the microbial cell segment is expected to follow a higher CAGR of 14.3% through the forecast years.
Demand for microbial cell line banking is higher among specialist biopharmaceutical companies as the research for new medicines is frequently carried out using microbial systems like yeast or bacteria. Moreover, microbial systems are employed for the synthesis of enzymes, recombinant proteins, and vaccines which is expected to drive this segment further.
Why Biopharmaceutical Companies Hold Sway over Whole GMP Cell Banking Services Market?
“Efficiency and Quality Assurance Obligations of Biopharmaceutical Companies is at the Heart”
Based on a survey of different end-use verticals for GMP cell banking service providers, the biopharmaceutical companies contribute to more than 70% of the total demand. The analysis of the numbers pegs the CAGR for this segment at 13.3% during the period between 2024 and 2034.
GMP cell banking services are essential for all biopharmaceutical companies to guarantee the consistency, quality, and legal compliance of the cell lines utilized in the creation of novel drugs. In addition to this, GMP cell banking services shorten the time needed for the development and commercialization of treatments by offering ready-to-use and compliant cell banks.
Why Contract Manufacturing Companies are Requiring GMP Cell Banking Services Nowadays?
“Biopharmaceutical Companies are Outsourcing to CMOs More These Days”
According to market analysis, contract manufacturing companies' demand for GMP cell banking services is expected to rise at a 13.9% CAGR through 2034.
Biopharmaceutical firms outsourcing particular phases of the production process to contract manufacturing organizations (CMOs) is an emerging trend these days. Biopharmaceutical businesses also obtain infrastructure and knowledge at a reasonable cost by working with CMOs, as building up internal cell line banking capabilities can be resource-intensive.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
As per the industry survey report, though many market players are competing at present, the scattered presence of these companies is what makes it diversified. By prioritizing regulatory compliance, established service providers build industry confidence and trustworthiness and control a sizable share of the global market. However, some new market players who are providing scalable and adaptable solutions to meet the various needs of gene therapy and cell therapy researchers are observed to be growing fast against even leading market players.
Recent Developments by the GMP Cell Banking Service Providers
In April 2022, FUJIFILM Corporation acquired Atara Biotherapeutics Incorporate, which is an exclusive cell therapy manufacturing company in the United States. Through this acquisition, FUJIFILM Co., a leading contract development and manufacturing organization, also announced the production of both clinical and commercial cell therapies, such as allogeneic T-cell and CAR T immunotherapies.
In June 2021, Mecart created a Grade C cell banking cleanroom with its proficiency in creating biotech cleanrooms. All of the equipment required for cell banking operations is located in the grade C cleanroom area. The firm itself employs virus-like particles (VLP) to create vaccines. Production of cell banks must adhere to the cGMP cleanroom and manufacturing specifications mandated by regulating agencies like the US FDA or Health Canada.
Segmentation of GMP Cell Banking Service Market Research
-
By Cell Type:
- Mammalian
- Microbial
- Insect
- Yeast
- Avian
- Stem
- Others
-
By End User:
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
-
By Region:
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- The Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Cell Type
- 5.1. Mammalian
- 5.2. Microbial
- 5.3. Insect
- 5.4. Yeast
- 5.5. Avian
- 5.6. Stem Cell
- 5.7. Others
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 6.1. Biopharmaceutical Companies
- 6.2. Contract Manufacturing Organizations
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 7.1. North America
- 7.2. Latin America
- 7.3. Western Europe
- 7.4. Eastern Europe
- 7.5. South Asia and Pacific
- 7.6. East Asia
- 7.7. Middle East and Africa
- 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 15. Key Countries Market Analysis
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. WuXi AppTec
- 17.2. Charles River Laboratories International, Inc.
- 17.3. Eurofins Scientific
- 17.4. Merck KGaA
- 17.5. Lonza Group Ltd
- 17.6. SGS Ltd
- 17.7. ViruSure GmbH
- 17.8. Austrianova
- 17.9. Goodwin Biotechnology Inc.
- 17.10. Paragon Bioservices, Inc.
- 18. Assumptions & Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Cell Type, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 4: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Cell Type, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 8: Latin America Market Value (US$ Million) Forecast by Cell Type, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 11: Western Europe Market Value (US$ Million) Forecast by Cell Type, 2019 to 2034
Table 12: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Eastern Europe Market Value (US$ Million) Forecast by Cell Type, 2019 to 2034
Table 15: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Cell Type, 2019 to 2034
Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 20: East Asia Market Value (US$ Million) Forecast by Cell Type, 2019 to 2034
Table 21: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Cell Type, 2019 to 2034
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Million) by Cell Type, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 7: Global Market Value (US$ Million) Analysis by Cell Type, 2019 to 2034
Figure 8: Global Market Value Share (%) and BPS Analysis by Cell Type, 2024 to 2034
Figure 9: Global Market Y-o-Y Growth (%) Projections by Cell Type, 2024 to 2034
Figure 10: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 13: Global Market Attractiveness by Cell Type, 2024 to 2034
Figure 14: Global Market Attractiveness by End User, 2024 to 2034
Figure 15: Global Market Attractiveness by Region, 2024 to 2034
Figure 16: North America Market Value (US$ Million) by Cell Type, 2024 to 2034
Figure 17: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 18: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 22: North America Market Value (US$ Million) Analysis by Cell Type, 2019 to 2034
Figure 23: North America Market Value Share (%) and BPS Analysis by Cell Type, 2024 to 2034
Figure 24: North America Market Y-o-Y Growth (%) Projections by Cell Type, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 28: North America Market Attractiveness by Cell Type, 2024 to 2034
Figure 29: North America Market Attractiveness by End User, 2024 to 2034
Figure 30: North America Market Attractiveness by Country, 2024 to 2034
Figure 31: Latin America Market Value (US$ Million) by Cell Type, 2024 to 2034
Figure 32: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 33: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 37: Latin America Market Value (US$ Million) Analysis by Cell Type, 2019 to 2034
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Cell Type, 2024 to 2034
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Cell Type, 2024 to 2034
Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 43: Latin America Market Attractiveness by Cell Type, 2024 to 2034
Figure 44: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 45: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 46: Western Europe Market Value (US$ Million) by Cell Type, 2024 to 2034
Figure 47: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 48: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 52: Western Europe Market Value (US$ Million) Analysis by Cell Type, 2019 to 2034
Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Cell Type, 2024 to 2034
Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Cell Type, 2024 to 2034
Figure 55: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 58: Western Europe Market Attractiveness by Cell Type, 2024 to 2034
Figure 59: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 60: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 61: Eastern Europe Market Value (US$ Million) by Cell Type, 2024 to 2034
Figure 62: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Cell Type, 2019 to 2034
Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Cell Type, 2024 to 2034
Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Cell Type, 2024 to 2034
Figure 70: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 73: Eastern Europe Market Attractiveness by Cell Type, 2024 to 2034
Figure 74: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 75: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 76: South Asia and Pacific Market Value (US$ Million) by Cell Type, 2024 to 2034
Figure 77: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Cell Type, 2019 to 2034
Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Cell Type, 2024 to 2034
Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Cell Type, 2024 to 2034
Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 88: South Asia and Pacific Market Attractiveness by Cell Type, 2024 to 2034
Figure 89: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 90: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 91: East Asia Market Value (US$ Million) by Cell Type, 2024 to 2034
Figure 92: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 93: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 97: East Asia Market Value (US$ Million) Analysis by Cell Type, 2019 to 2034
Figure 98: East Asia Market Value Share (%) and BPS Analysis by Cell Type, 2024 to 2034
Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Cell Type, 2024 to 2034
Figure 100: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 101: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 102: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 103: East Asia Market Attractiveness by Cell Type, 2024 to 2034
Figure 104: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 105: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 106: Middle East and Africa Market Value (US$ Million) by Cell Type, 2024 to 2034
Figure 107: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Cell Type, 2019 to 2034
Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Cell Type, 2024 to 2034
Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Cell Type, 2024 to 2034
Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 118: Middle East and Africa Market Attractiveness by Cell Type, 2024 to 2034
Figure 119: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 120: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the Sales Outlook for GMP Cell Banking Service in 2024?
The market value for GMP cell banking service could be US$ 882.1 million in 2024.
What was the Value of the GMP Cell Banking Service Market in 2019?
The global GMP cell banking service market was worth US$ 450.1 million in 2019.
What is the Demand Forecast for GMP Cell Banking Service through 2034?
GMP cell banking service market value is projected to reach US$ 3,123.5 million by 2034.
What is the Adoption Growth Projection for the GMP Cell Banking Service?
Adoption of GMP cell banking services is likely to rise at a CAGR of 13.5% through 2034.
At What Rate Is the Market in North America Predicted to Grow?
The North America market is forecast to expand at a CAGR of 13% through 2034.
GMP Cell Banking Service Market